Skip to content
Ultimate Cards Studio

Users Coming Off Anti-Obesity Medications Put On Weight Four Times Faster Than People Using Diet and Exercise

Illustration of medical syringe and scale
Obesity treatment often requires ongoing approaches.

A recent study indicates that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who stop traditional lifestyle programs.

Findings released in a prominent health publication points out that while overweight individuals often shed substantial amounts of their total mass while on the medication, the weight returns at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such medications need to be cognizant of the potential of quick weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.

This pace of regain suggests a return to starting weight in about a year and a half.

Analyzing Approaches

The analysis, which looked at 37 of trials involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with other pills.

Scientists point out that people who shed pounds through diet and exercise generally experience a less rapid weight regain—approximately 0.1 kg a month—after stopping.

The Reason for the Fast Rebound

Doctors suggest the way of the drugs is key to understanding the amplified weight return.

GLP-1 drugs mimic a natural hormone called GLP-1, which controls hunger.

"Long-term administration of the hormone concentrations far above than normal could lead to the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making binge eating a significant risk."

A Lifelong Disease?

The NHS advise the jabs for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.

A number of clinicians say that, due to the likelihood of relapse, the therapy might need to be long-term.

This view is echoed by pharmaceutical companies, who say that the findings "emphasize the long-term nature of excess weight," akin to managing diseases like diabetes.

Patient Testimonies

Users who have stopped the medication explain a intense return of cravings.

"I experienced a trigger that goes on and you're instantly ravenous," recalled an individual.

The struggle is exacerbated if individuals have not adopted lasting lifestyle or habit changes during treatment.

Widespread Interest

Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with desire remaining high.

  • Adoption is higher among females than men.
  • The middle-aged demographic shows the highest level of interest.
  • Many obtain the medications through private healthcare rather than public health services.

Ultimately, clinicians emphasize that while the jabs are potent agents for weight loss, they are not a magic fix and lasting health benefits likely depends on integrated behavioural changes.

By

Pamela Watson

A creative designer and printing expert with over a decade of experience in custom card solutions and visual branding.

Ultimate Cards Studio

Type to search articles.